Literature DB >> 3606605

Steroid receptor antibodies in autoimmune disorders.

M Feldman.   

Abstract

Sera from patients with autoimmune disorders have been analyzed for the presence of antibodies against the estrogen receptor. About 42% of the male and 34% of the female patients had measureable levels of antibody under our assay conditions. However, whereas the male patient population had significantly higher levels of anti-estrogen receptor than normal males, there was no significant difference between female patients and controls. Separation of the estrogen receptor by sucrose gradient centrifugation into the large (9-10S) and small (4S) molecular weight forms demonstrated that only the large form was antigenic, suggesting that the antibodies are not interacting with the steroid binding subunit. The clinical significance of increased levels of antibodies against the estrogen receptor in a percentage of male patients remains to be established.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3606605     DOI: 10.1016/0006-291x(87)91585-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study.

Authors:  Ji-An Liang; Li-Min Sun; Jun-Jun Yeh; Wan-Yu Lin; Shih-Ni Chang; Hung-Chang Sung; Chia-Hung Kao
Journal:  Rheumatol Int       Date:  2010-12-31       Impact factor: 2.631

Review 2.  Pathogenic roles of autoantibodies in systemic sclerosis: Current understandings in pathogenesis.

Authors:  Jean-Luc Senécal; Sabrina Hoa; Roger Yang; Martial Koenig
Journal:  J Scleroderma Relat Disord       Date:  2019-09-09

3.  Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation.

Authors:  Angela Maselli; Sara Capoccia; Patrizia Pugliese; Carla Raggi; Francesca Cirulli; Alessandra Fabi; Walter Malorni; Marina Pierdominici; Elena Ortona
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

Review 4.  Immunomodulation of carcinogens-induced steroids-dependent human diseases.

Authors:  Andrew N Glushkov; Elena G Polenok
Journal:  Saudi J Biol Sci       Date:  2017-10-03       Impact factor: 4.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.